Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    October 2022
  1. REIS BS, Nogueira CM, Meneses AFP, Mellado BH, et al
    Experiences of women with advanced cervical cancer before starting the treatment: Systematic review of qualitative studies.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14491.
    PubMed     Abstract available


  2. SEOUD M, Jaafar I, Hamadeh R, Ammar W, et al
    Feasibility of Implementing Cytology Based Cervical Cancer Screening National Program in Lebanon: A pilot Study.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14489.
    PubMed     Abstract available


    September 2022
  3. MAILLIE L, Yussuph A, Chirangi B, Schroeder K, et al
    Outcomes From Eight Years of Cervical Cancer Screening at a Rural Screen-and-Treat Site in Northern Tanzania.
    Int J Gynaecol Obstet. 2022 Sep 2. doi: 10.1002/ijgo.14429.
    PubMed     Abstract available


    August 2022
  4. DAU H, Trawin J, Nakisige C, Payne BA, et al
    The social and economic impacts of cervical cancer on women and children in low- and middle-income countries: a systematic review.
    Int J Gynaecol Obstet. 2022 Aug 13. doi: 10.1002/ijgo.14395.
    PubMed     Abstract available


    July 2022
  5. HU SY, Zhao XL, Zhao FH, Wei LH, et al
    Implementation of Visual Inspection with Acetic Acid and Lugol's Iodine for Cervical Cancer Screening in Rural China.
    Int J Gynaecol Obstet. 2022 Jul 24. doi: 10.1002/ijgo.14368.
    PubMed     Abstract available


    June 2022
  6. FRICK A, Azuaga A, Abdulcadir J
    Cervical dysplasia among migrant women with female genital mutilation/cutting type III: A cross-sectional study.
    Int J Gynaecol Obstet. 2022;157:557-563.
    PubMed     Abstract available


    April 2022
  7. CIAVATTINI A, Di Giuseppe J, Marconi C, Giannella L, et al
    Hysterectomy for cervical intraepithelial neoplasia: A Retrospective observational multi-institutional study.
    Int J Gynaecol Obstet. 2022 Apr 27. doi: 10.1002/ijgo.14233.
    PubMed     Abstract available


  8. THIANGPHAK E, Pruegsanusak K, Buhachat R
    Pretreatment lymphocyte count as independent prognostic factor in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Int J Gynaecol Obstet. 2022 Apr 23. doi: 10.1002/ijgo.14229.
    PubMed     Abstract available


    February 2022
  9. TAWIAH A, Konney TO, Dassah ET, Visser LE, et al
    Determinants of Cervical Cancer Screening Uptake Among Women with Access to Free Screening: A Community-Based Study in Peri-Urban Ghana.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14158.
    PubMed     Abstract available


  10. ZHANG Y, Huang Y, Luo S, Li L, et al
    Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
    Int J Gynaecol Obstet. 2022 Feb 5. doi: 10.1002/ijgo.14125.
    PubMed     Abstract available


    January 2022
  11. SETIAWAN D, Miranti I, Partiwi TD, Puspitasari DA, et al
    The Willingness of Cervical Cancer Screening Among Sexually Active Women in Indonesia: Lesson Learned from 2 Districts.
    Int J Gynaecol Obstet. 2022 Jan 25. doi: 10.1002/ijgo.14113.
    PubMed     Abstract available


  12. FU K, Lei M, Yang WQ, Wu LS, et al
    The treatment strategy of patients with positive margins after cervical cold knife conization-A 7-year retrospective study in China.
    Int J Gynaecol Obstet. 2022;156:159-165.
    PubMed     Abstract available


    December 2021
  13. RAMIREZ M, de la Fuente J, Andia D, Hernandez JJ, et al
    "HPV vaccination coverage in women between 15-55 years in Spain. Temporal trend during the period 2007-2020".
    Int J Gynaecol Obstet. 2021 Dec 14. doi: 10.1002/ijgo.14067.
    PubMed    


  14. AYDIN S, Karasu AFG, Marasli M, Bademler N, et al
    Reliability and diagnostic performance of smartphone colposcopy.
    Int J Gynaecol Obstet. 2021;155:404-410.
    PubMed     Abstract available


    November 2021
  15. TU Y, Jiang P, Zhang J, Jiang S, et al
    The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer.
    Int J Gynaecol Obstet. 2021 Nov 4. doi: 10.1002/ijgo.14005.
    PubMed     Abstract available


    October 2021
  16. BISPO PEREIRA EH, Camilo-Junior DJ, D'avilla SCGP, Mattar NJ, et al
    Comparison of Cervical Cancer Screening Results Among Public and Private Services in Brazil.
    Int J Gynaecol Obstet. 2021 Oct 16. doi: 10.1002/ijgo.13985.
    PubMed     Abstract available


  17. OISHI T, Kigawa J, Iwanari O, Kasai T, et al
    Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Int J Gynaecol Obstet. 2021 Oct 4. doi: 10.1002/ijgo.13961.
    PubMed     Abstract available


  18. WILAILAK S, Kengsakul M, Kehoe S
    Worldwide initiatives to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:102-106.
    PubMed     Abstract available


  19. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available


  20. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:28-44.
    PubMed     Abstract available


  21. RANDALL TC, Somashekhar SP, Chuang L, Ng JS, et al
    Reaching the women with the greatest needs: Two models for initiation and scale-up of gynecologic oncology fellowship trainings in low-resource settings.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:115-122.
    PubMed     Abstract available


  22. ADAMS TS, Rogers LJ, Cuello MA
    Cancer of the vagina: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:19-27.
    PubMed     Abstract available


    September 2021
  23. SANCHEZ-CUERDA C, Cuadra M, Gamir S, Lobo P, et al
    Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
    Int J Gynaecol Obstet. 2021 Sep 24. doi: 10.1002/ijgo.13948.
    PubMed     Abstract available


  24. DICK A, Holyk T, Taylor D, Wenninger C, et al
    Highlighting strengths and resources that increase ownership of cervical cancer screening for Indigenous communities in Northern British Columbia: Community-driven approaches.
    Int J Gynaecol Obstet. 2021 Sep 8. doi: 10.1002/ijgo.13915.
    PubMed     Abstract available


  25. NKWABONG E, Kengne B, Nkene Mawamba Y, Sando Z, et al
    Influence of the human immunodeficiency virus on cervical precancerous lesions.
    Int J Gynaecol Obstet. 2021;154:540-543.
    PubMed     Abstract available


  26. JELINEK K, Harding L, Briceno R, Li Z, et al
    Prevalence of high-risk human papillomavirus genotypes in two regions of Peru.
    Int J Gynaecol Obstet. 2021;154:544-549.
    PubMed     Abstract available


    August 2021
  27. ADCOCK A, Stevenson K, Cram F, MacDonald EJ, et al
    He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Maori women talk about HPV self-testing cervical screening clinical pathways.
    Int J Gynaecol Obstet. 2021 Aug 11. doi: 10.1002/ijgo.13873.
    PubMed     Abstract available


  28. CHO HW, Hong JH, Lee JK
    Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Int J Gynaecol Obstet. 2021;154:227-232.
    PubMed     Abstract available


    July 2021
  29. MUNGO C, Randa M, Shauri A, Serem D, et al
    Characteristics, stage at presentation, and status of women with cervical cancer at a major referral center in western Kenya.
    Int J Gynaecol Obstet. 2021 Jul 20. doi: 10.1002/ijgo.13831.
    PubMed     Abstract available


  30. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed     Abstract available


  31. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed     Abstract available


    June 2021
  32. YU Y, Deng T, Gu S
    Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Int J Gynaecol Obstet. 2021 Jun 24. doi: 10.1002/ijgo.13796.
    PubMed     Abstract available


  33. TREJO MJ, Soliman AS, Chen Y, Kalima M, et al
    Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Int J Gynaecol Obstet. 2021 Jun 14. doi: 10.1002/ijgo.13784.
    PubMed     Abstract available


    May 2021
  34. TESKERECI G, Arslan UO, Oncel S
    The awareness levels of women on gynecological cancer in Turkey: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 May 18. doi: 10.1002/ijgo.13745.
    PubMed     Abstract available


  35. SOFTELAND S, Sebitloane MH, Taylor M, Roald BB, et al
    A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.
    Int J Gynaecol Obstet. 2021;153:190-199.
    PubMed     Abstract available


    April 2021
  36. DORJI T, Tshomo U, Gyamtsho S, Tamang ST, et al
    Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan.
    Int J Gynaecol Obstet. 2021 Apr 30. doi: 10.1002/ijgo.13728.
    PubMed     Abstract available


    March 2021
  37. KEMPER KE, McGrath CJ, Eckert LO, Kinuthia J, et al
    Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 Mar 30. doi: 10.1002/ijgo.13690.
    PubMed     Abstract available


  38. AGAROSSI A, Delli Carpini G, Sopracordevole F, Serri M, et al
    High-risk HPV positivity is a long-term risk factor for recurrence after cervical excision procedure in women living with HIV.
    Int J Gynaecol Obstet. 2021 Mar 15. doi: 10.1002/ijgo.13674.
    PubMed     Abstract available


    February 2021
  39. TANG X, Qiu J, Guo C, Guo J, et al
    A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Int J Gynaecol Obstet. 2021 Feb 15. doi: 10.1002/ijgo.13644.
    PubMed     Abstract available


  40. MARINGA VD, Chikandiwa A, Gilham C, Mbodi L, et al
    Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2021;152:188-195.
    PubMed     Abstract available


    January 2021
  41. KRAMER J
    Eradicating cervical cancer: Lessons learned from Rwanda and Australia.
    Int J Gynaecol Obstet. 2021 Jan 17. doi: 10.1002/ijgo.13601.
    PubMed     Abstract available


  42. TAMAUCHI S, Kajiyama H, Osuka S, Moriyama Y, et al
    Reduced response to controlled ovarian stimulation after radical trachelectomy: A pitfall of fertility-sparing surgery for cervical cancer.
    Int J Gynaecol Obstet. 2021 Jan 13. doi: 10.1002/ijgo.13529.
    PubMed     Abstract available


  43. CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
    Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
    Int J Gynaecol Obstet. 2021;152:118-124.
    PubMed     Abstract available


  44. LIU P, Dai E, Li W, He F, et al
    Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2021;152:125-132.
    PubMed     Abstract available


  45. BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
    Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
    Int J Gynaecol Obstet. 2021;152:72-77.
    PubMed     Abstract available


  46. LI Y, Wang H, Zhang Y, Jing X, et al
    Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
    Int J Gynaecol Obstet. 2021;152:96-102.
    PubMed     Abstract available


  47. YANG Y, Hu T, Ming X, Yang E, et al
    REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Int J Gynaecol Obstet. 2021;152:82-87.
    PubMed     Abstract available


    December 2020
  48. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed     Abstract available


  49. TEIXEIRA JC, Santos DZ, Campos CS, Vale DB, et al
    Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes.
    Int J Gynaecol Obstet. 2020 Dec 20. doi: 10.1002/ijgo.13553.
    PubMed     Abstract available


  50. SIMELELA PN
    WHO global strategy to eliminate cervical cancer as a public health problem: An opportunity to make it a disease of the past.
    Int J Gynaecol Obstet. 2020 Dec 2. doi: 10.1002/ijgo.13484.
    PubMed    


    November 2020
  51. BHATLA N, Nessa A, Oswal K, Vashist S, et al
    Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.
    Int J Gynaecol Obstet. 2020 Nov 18. doi: 10.1002/ijgo.13486.
    PubMed     Abstract available


  52. ROHNER E, Mulongo M, Pasipamire T, Oberlin AM, et al
    Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2020 Nov 14. doi: 10.1002/ijgo.13485.
    PubMed     Abstract available


  53. ALLENDE-PEREZ S, Dominguez-Ocadio G, Velez-Salas V, Isla D, et al
    Snapshot of symptoms of advanced cervical cancer patients referred to the palliative care service in a cancer center in Mexico.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13479.
    PubMed     Abstract available


  54. KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
    Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
    PubMed     Abstract available


  55. KENGSAKUL M, Laowahutanont P, Wilailak S
    Experiences in the prevention and screening of cervical cancer within Thailand.
    Int J Gynaecol Obstet. 2020 Nov 12. doi: 10.1002/ijgo.13481.
    PubMed     Abstract available


  56. LINDEQUE G
    A perspective on cervical cancer prevention and screening in Africa.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13476.
    PubMed     Abstract available


  57. SHOU H, Yasuo Y, Yuan S, Lou H, et al
    Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis.
    Int J Gynaecol Obstet. 2020 Nov 3. doi: 10.1002/ijgo.13465.
    PubMed     Abstract available


  58. DANIEL GO, Musa J, Akindigh TM, Shinku F, et al
    Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Int J Gynaecol Obstet. 2020;151:253-259.
    PubMed     Abstract available


    October 2020
  59. RAWAT A, Sanders C, Mithani N, Amuge C, et al
    Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13454.
    PubMed     Abstract available


  60. VALE DB, Teixeira JC, Braganca JF, Derchain S, et al
    Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13458.
    PubMed     Abstract available


  61. MAGDI R, Elshafeey F, Elshebiny M, Kamel M, et al
    A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Int J Gynaecol Obstet. 2020 Oct 30. doi: 10.1002/ijgo.13455.
    PubMed     Abstract available


  62. OKADOME M, Nagayama R, Shimokawa M, Sonoda K, et al
    Prognosis of bulky pT2b cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Int J Gynaecol Obstet. 2020 Oct 29. doi: 10.1002/ijgo.13451.
    PubMed     Abstract available


  63. LAWAL IK, Suleiman AK, Bagudu Z, Kanmodi KK, et al
    Planning and advocating for cervical cancer prevention in Kebbi State, Nigeria: Learning points for the global call to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2020 Oct 8. doi: 10.1002/ijgo.13414.
    PubMed     Abstract available


  64. YIM ET, Rogers TB, Msami K, Calixte R, et al
    Factors related to completion of referral among women with suspected cervical cancer and dysplasia in Tanzania.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13412.
    PubMed     Abstract available


    September 2020
  65. HOQUE MR, Haque E, Karim MR
    Cervical cancer in low-income countries: A Bangladeshi perspective.
    Int J Gynaecol Obstet. 2020 Sep 28. doi: 10.1002/ijgo.13400.
    PubMed     Abstract available


    July 2020
  66. ORANG'O EO, Emont JP, Ermel AC, Liu T, et al
    Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
    Int J Gynaecol Obstet. 2020 Jul 26. doi: 10.1002/ijgo.13330.
    PubMed     Abstract available


    June 2020
  67. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available


    April 2020
  68. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
    Int J Gynaecol Obstet. 2020 Apr 27. doi: 10.1002/ijgo.13185.
    PubMed     Abstract available


    February 2020
  69. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
    The rising relative and absolute incidence of uterine cancer in specific populations.
    Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: